Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 19 de mar. de 2019 · The Vein of Marshall Ethanol for Unablated Persistent AF (VENUS) trial tested the hypothesis that adding vein of Marshall ethanol infusion to de novo catheter ablation of persistent AF could lead to increased chances of maintaining normal rhythm.

  2. 27 de oct. de 2020 · Design, setting, and participants: The Vein of Marshall Ethanol for Untreated Persistent AF (VENUS) trial was an investigator-initiated, National Institutes of Health-funded, randomized, single-blinded trial conducted in 12 centers in the United States.

  3. Venus on Trial (German: Venus vor Gericht) is a 1941 German drama film directed by Hans H. Zerlett and starring Hannes Stelzer, Hansi Knoteck, and Paul Dahlke. The film was part of the Nazis' campaign against 'degenerate art', and depicts the trial of a young artist who has resisted the trend towards it.

  4. 4 de abr. de 2021 · Valderrábano and colleagues recently published results from the VENUS trial (Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation), a randomized controlled clinical trial that evaluated the therapeutic role of VOM ethanol ablation in treating persistent AF.20, 21 A total of 343 patients were randomized to either ...

  5. 24 de abr. de 2018 · In a trial conducted at 20 centers in the United Kingdom, we randomly assigned 450 patients with venous leg ulcers to receive compression therapy and undergo early endovenous ablation of...

  6. 29 de abr. de 2022 · Our meta-analysis demonstrates that VOM-ABL has superior efficacy and comparable safety compared to ablation alone in AF patients with long-term follow-up. Moreover, PVI+ and VOM-ABL group sample size ≥ 100 may be associated with a great impact on freedom from AF/AT and MI block, respectively.

  7. Objective: To test the safety and efficacy of VOM ethanol infusion when added to PVI in patients undergoing either de novo ablation of persistent AF or after a previous ablation failure. Study design: VENUS-AF and MARS-AF are prospective, multicenter, randomized, controlled trials.